Maddalena Adorno

Alright, so here’s the lowdown on Maddalena Adorno, this lady is the real deal. She’s a total boss in biotech, and her story is straight-up inspiring. No fancy fluff, just the real process of someone who jumped into the deep end and crushed it.

So, Maddalena’s been deep in the science trenches for over a decade. She started out with a solid academic background, PhD in Bioscience, a Master’s in Medical Biotechnology, and even pre-clinical MD training. Basically, she’s got the brains and the grind to back it up. She cut her teeth at Uni of Padova and Verona, then jumped into Stanford’s med school, where she didn’t just hang out, she crushed research in stem cells and cancer stem cells. She was a Siebel Scholar, which is a big deal, and she spent almost a decade as a postdoc there, diving into aging biology and regenerative medicine.

Now, here’s where it gets interesting. While at Stanford, she met Benedetta di Robilant, their chemistry was instant, and they co-founded Dorian Therapeutics in 2018. The goal? Tackling age-related diseases by developing senoblockers, which basically are drugs that target aging at the cellular level. Think about it, they’re trying to fix aging, not just symptoms. That’s some advanced stuff. Maddalena’s been all about pushing the envelope on aging and degenerative diseases.

But she didn’t stop there. She was also a scientific co-founder at StemGuard, working on neuroprotectors for degenerative brain stuff, which shows her focus on aging and decline is not just a side gig. She’s been involved in startups, participated in Y Combinator’s Bio batch, and got early investment support from top folks like StartX. She’s been recognized for her brilliance, speaking at big events like the Time 100 Health Summit, and even advising organizations like Stanford’s Down Syndrome Center.

Fast forward to 2025, Dorian Therapeutics gets snapped up by Altos Labs. That’s huge. It’s a clear sign her work is not just original but also highly useful. She’s proven that her approach works, and her team’s work is the real deal.

What does all this tell you? Maddalena is a relentless innovator. She’s driven by a deep curiosity about aging and a desire to change how we treat age-related diseases. She’s not just in it for the science, she wants to make a real impact, and she’s willing to jump into the messy, risky startup world to do it. That’s what makes her story so convincing: she’s a scientist turned entrepreneur who’s not afraid to take big swings.

Bottom line: Maddalena is a pioneer in aging biotech, a true science and startup all-star, and someone who’s out here not just talking about the future, she’s building it. When you see her process, it’s obvious she’s built for this, driven, smart, and totally committed to making a difference. No cap.